HC Wainwright & Co. Reiterates Buy on Sophia Genetics, Maintains $14 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a Buy rating on Sophia Genetics (NASDAQ: SOPH) and maintained a price target of $14 for the stock.